Building Engagement Using Financial Incentives Trial - Colorectal Cancer Screening
Purpose
The goal of this pilot clinical trial is to determine feasibility and explore whether financial incentives paid to primary care patients for completing colorectal cancer screening increase completion of colorectal cancer screening. The main questions it aims to answer are: - Do patient financial incentives for completing colorectal cancer screening increase screening completion? - Does a patient financial incentive for colorectal cancer screening offered alongside patient financial incentives for COVID-19 and flu shots increase completion of those shots? Participants who are due for colorectal cancer screening will receive telephone outreach from primary care staff who will offer a stool-based colorectal cancer screening. Participants will be randomly assigned to either Group 1 or Group 2. Group 1 participants will be offered financial incentives for completing COVID-19 and flu shots within 2 months of enrollment. Group 2 participants will be offered financial incentives for completing a COVID-19 shot, a flu shot, and colorectal cancer screening within 2 months of enrollment. Researchers will compare to see if completion of a COVID-19 shot, a flu shot, and colorectal cancer screening is different between the two groups.
Conditions
- Health Behavior
- Colorectal Cancer
- Influenza
- COVID-19
- Vaccine Hesitancy
- Vaccine-Preventable Diseases
- Healthcare Patient Acceptance
Eligibility
- Eligible Ages
- Between 45 Years and 75 Years
- Eligible Genders
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- Age 45 to 75 - Receive care at participating primary care clinic - Due for colorectal cancer screening - Ability to understand and speak English
Exclusion Criteria
- Currently participating in another clinical trial or research study on colorectal cancer screening - Unable or unwilling to give informed consent
Study Design
- Phase
- N/A
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel Assignment
- Intervention Model Description
- Participants will be randomly assigned to a study arm for the duration of their two months in the study
- Primary Purpose
- Screening
- Masking
- Double (Care Provider, Outcomes Assessor)
- Masking Description
- Primary care outreach staff will recruit and randomize participants and deliver the intervention. Group assignment will be documented in a separate study database not accessible by the primary care provider. Outcomes will be assessed in electronic health records data, which will be queried by primary care staff who do not have access to group assignment.
Arm Groups
Arm | Description | Assigned Intervention |
---|---|---|
Experimental Full financial incentives |
$50/service patient financial incentive for completion of: COVID-19 shot, flu shot, colorectal cancer screening |
|
Active Comparator Partial financial incentives |
$50/service patient financial incentive for completion of: COVID-19 shot, flu shot |
|
Recruiting Locations
More Details
- NCT ID
- NCT06124131
- Status
- Completed
- Sponsor
- Tulane University